Is NGNE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NGNE. It does not provide personalized investment advice.

NGNE (Neurogene, Inc. Common Stock) Stock Analysis - Financials

Neurogene, Inc. Common Stock (NGNE) is a publicly traded Healthcare sector company. As of October 5, 2026, NGNE trades at $26.46 with a market cap of $513.29M and a P/E ratio of -6.04. NGNE moved +3.31% today. Year to date, NGNE is +28.50%; over the trailing twelve months it is +18.49%. Its 52-week range spans $6.88 to $43.66. Analyst consensus is strong buy with an average price target of $84.20. Rallies surfaces NGNE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are NGNE's key financials?

NGNE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NGNE recently traded at $26.46. Market cap is $513.29M. P/E ratio is -6.04. Revenue is $0.

NGNE Key Metrics

Key financial metrics for NGNE
Metric	Value
Price	$26.46
Market Cap	$513.29M
P/E Ratio	-6.04
EPS	$-4.24
Dividend Yield	0.00%
52-Week High	$43.66
52-Week Low	$6.88
Volume	184.40K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-90.35M
Gross Margin	0.00%

NGNE Analyst Consensus

7 analysts cover NGNE: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $84.20.

Common questions about NGNE

What are NGNE's key financials?: NGNE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NGNE recently traded at $26.46. Market cap is $513.29M. P/E ratio is -6.04. Revenue is $0.
Is NGNE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NGNE. It does not provide personalized investment advice.